Open Access Oral Drug Therapy for Erectile Dysfunction: Overview and Aeromedical Implications

Authors: Alon Grossman; Erez Barenboim; Bella Azaria; Yaniv Sherer; Liav Goldstein

Source: Aviation, Space, and Environmental Medicine, Volume 75, Number 11, November 2004 , pp. 997-1000(4)

Publisher: Aerospace Medical Association

Buy & download fulltext article:

Open Access The full text is Open Access.

View now:
PDF 64.7kb 

Abstract:

Grossman A, Barenboim E, Azaria B, Sherer Y, Goldstein L. Oral drug therapy for erectile dysfunction: overview and aeromedical implications. Aviat Space Environ Med 2004; 75:9971000.

Approximately 150 million men worldwide experience erectile dysfunction, whereby they are unable to maintain an erection adequate for satisfactory sexual performance. This population is projected to more than double in the next 25 yr. Introduction of the phosphodiesterase inhibitors has revolutionized the management of this common problem, encouraging many more men to seek treatment. The issue of erectile dysfunction treatment is a growing concern in the aviation community as well. This is particularly relevant in civil aviation, as this population is older and has co-morbidities that may contribute to the development of erectile dysfunction. In this article we will review the available options for oral treatment of erectile dysfunction and discuss implications regarding their use in aviators based on the information available in the literature.

Keywords: aerospace medicine; aviators; erectile dysfunction; sildenafil; tadalafil; vardenafil

Document Type: Research article

Publication date: 2004-11-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page